CollPlant Biotechnologies Ltd financial data

Symbol
CLGN on Nasdaq
Location
Rehovot, Israel
Fiscal year end
31 December
Latest financial report
6-K - Q2 2025 - 20 Aug 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11,454,512 shares 0.02%
Common Stock, Shares, Outstanding 12,716,014 shares 11%
Common Stock, Value, Issued $5,492,000 USD 10%
Weighted Average Number of Shares Outstanding, Basic 11,840,829 shares 3.4%
Weighted Average Number of Shares Outstanding, Diluted 11,840,829 shares 3.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $179,000 USD -28%
Cost of Revenue $186,000 USD -65%
Research and Development Expense $2,013,000 USD -25%
General and Administrative Expense $1,158,000 USD -19%
Operating Income (Loss) $3,178,000 USD 28%
Nonoperating Income (Expense) $169,000 USD -186%
Net Income (Loss) Attributable to Parent $3,347,000 USD 20%
Earnings Per Share, Basic 0.28 USD/shares -24%
Earnings Per Share, Diluted 0.28 USD/shares -24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $11,434,000 USD -40%
Accounts Receivable, after Allowance for Credit Loss, Current $150,000 USD
Inventory, Net $553,000 USD 26%
Assets, Current $12,624,000 USD -38%
Property, Plant and Equipment, Net $1,857,000 USD -27%
Operating Lease, Right-of-Use Asset $2,724,000 USD -20%
Intangible Assets, Net (Excluding Goodwill) $102,000 USD -36%
Assets $17,437,000 USD -34%
Liabilities, Current $2,742,000 USD -15%
Operating Lease, Liability, Noncurrent $2,190,000 USD -16%
Liabilities $4,932,000 USD -16%
Accumulated Other Comprehensive Income (Loss), Net of Tax $969,000 USD 0%
Retained Earnings (Accumulated Deficit) $118,149,000 USD -12%
Stockholders' Equity Attributable to Parent $12,505,000 USD -40%
Liabilities and Equity $17,437,000 USD -34%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 30,000,000 shares 0%
Common Stock, Shares, Issued 12,716,014 shares 11%
Common Stock, Par or Stated Value Per Share 1.5 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11,434,000 USD -40%
Deferred Tax Assets, Valuation Allowance $22,767,000 USD 18%
Deferred Tax Assets, Gross $23,455,000 USD 17%
Operating Lease, Liability $3,081,000 USD -2.5%
Lessee, Operating Lease, Liability, to be Paid $3,623,000 USD -5.2%
Property, Plant and Equipment, Gross $9,314,000 USD 5.4%
Operating Lease, Liability, Current $837,000 USD 6.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $831,000 USD 8.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $926,000 USD 12%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $542,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three $776,000 USD 17%
Deferred Tax Assets, Operating Loss Carryforwards $18,684,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Four $765,000 USD 20%
Share-based Payment Arrangement, Expense $356,000 USD -27%